data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Calithera Biosciences
(NASDAQ:CALA)
Calithera Biosciences, Inc. - Common Stock recently split on Wednesday, June 15, 2022 with a ratio of 1:20
2.60
0.01[0.39%]
At close: Jun 24
2.6808
0.0808[3.11%]
After Hours: 8:10AM EDT
Day High/Low2.54 - 2.74
52 Week High/Low0.14 - 2.85
Open / Close2.64 / 2.6
Float / Outstanding4.7M / 4.9M
Vol / Avg.96.9K / 3.6M
Mkt Cap12.6M
P/E-
50d Avg. Price0.57
Div / Yield-
Payout Ratio-
EPS-3.6
Total Float4.7M

Calithera Biosciences (NASDAQ:CALA), Quotes and News Summary

Calithera Biosciences (NASDAQ: CALA)

Day High/Low2.54 - 2.74
52 Week High/Low0.14 - 2.85
Open / Close2.64 / 2.6
Float / Outstanding4.7M / 4.9M
Vol / Avg.96.9K / 3.6M
Mkt Cap12.6M
P/E-
50d Avg. Price0.57
Div / Yield-
Payout Ratio-
EPS-3.6
Total Float4.7M
Benzinga - 3 days ago
Benzinga - 3 days ago
Benzinga - Jun 14, 2022, 12:51PM
Benzinga - May 18, 2022, 12:26PM
Benzinga - May 11, 2022, 7:40AM
Benzinga - Apr 21, 2022, 8:28AM
Benzinga - Apr 21, 2022, 8:22AM
Benzinga - Apr 8, 2022, 1:04PM
Benzinga - Apr 4, 2022, 4:35AM
Benzinga - Mar 31, 2022, 4:33PM
load more
Sector: Health Care.Industry: Biotechnology
Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm functions through the region of the US. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its lead product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-3.600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Calithera Biosciences Questions & Answers

Q
How do I buy Calithera Biosciences (CALA) stock?
A

You can purchase shares of Calithera Biosciences (NASDAQ: CALA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Calithera Biosciences's (CALA) competitors?
Q
What is the target price for Calithera Biosciences (CALA) stock?
A

The latest price target for Calithera Biosciences (NASDAQ: CALA) was reported by Wells Fargo on Wednesday, May 11, 2022. The analyst firm set a price target for 2.00 expecting CALA to fall to within 12 months (a possible -23.08% downside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Calithera Biosciences (CALA)?
A

The stock price for Calithera Biosciences (NASDAQ: CALA) is $2.6 last updated June 24, 2022, 8:00 PM UTC.

Q
Does Calithera Biosciences (CALA) pay a dividend?
A

There are no upcoming dividends for Calithera Biosciences.

Q
When is Calithera Biosciences (NASDAQ:CALA) reporting earnings?
A

Calithera Biosciences’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Calithera Biosciences (CALA) going to split?
A

There is no upcoming split for Calithera Biosciences.

Q
What sector and industry does Calithera Biosciences (CALA) operate in?
A

Calithera Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.